Bio-Techne
Protein and diagnostics solutions
- B2B
About Bio-Techne
A leading developer and manufacturer of high-quality purified proteins, reagent solutions, diagnostic products, and genomic tools for research and clinical use globally
Key facts
- Industry
- Biotechnology Research
- Company size
- 1,001–5,000 employees
- Headquarters
- Minneapolis, Minnesota, United States
- Revenue
- $1.2BFY2026, publicly reported
- Website
- bio-techne.com
- linkedin.com/company/bio-techne
Bio-Techne in the news
- Bio-Techne Corp. stock outperforms competitors on strong trading day
Bio-Techne stock demonstrated market strength by outperforming industry peers during a recent trading day.
- Bio-Techne Corp. stock outperforms competitors on strong trading day
Bio-Techne Corp. stock outperformed its industry rivals during a strong day of market trading.
- New Bispecific Antibody Characterization Workflow Might Change The Case For Investing In Bio-Techne (TECH)
Bio-Techne and Refeyn launched a streamlined protein characterization workflow for bispecific antibodies to drive growth in high-margin instrumentation.
- 3 Reasons TECH is Risky and 1 Stock to Buy Instead
Bio-Techne is facing financial underperformance characterized by slow organic growth, a lack of scale in the life sciences sector, and diminishing returns on invested capital.
- Bio-Techne Corporation Trade Ideas — XETR:TE1
Trading strategies and market analysis perspectives for Bio-Techne Corporation's stock on the XETR exchange.
Bio-Techne at a glance
Bio-Techne is a B2B company in the Biotechnology Research industry, headquartered in Minneapolis, Minnesota, United States.
Bio-Techne has 1,001–5,000 employees.
Bio-Techne's revenue is $1.2B (FY2026, publicly reported).
Selling to companies like Bio-Techne?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies